Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Benjamin

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Frontiers in Urology|August 8, 2025
Editorial: An outlook on urobiome: advances in understanding the role of urobiome in urological health and disease and its potential in biotherapeuticsHarris Onywera, Ramadhani Chambuso, David J Benjamin, et al.
JAMA Oncology|September 12, 2022
Association of Sociodemographic Characteristics With Survival Among Patients With Urachal Cancer in California From 1988 to 2019David J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
The Journal of Urology|November 24, 2012
Reproductive potential of men with obstructive azoospermia undergoing percutaneous sperm retrieval and intracytoplasmic sperm injection according to the cause of obstructionSandro C Esteves, Walter Lee, David J Benjamin, et al.
Clinical Lung Cancer|August 4, 2019
A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer RegistryDavid J Benjamin, Amy Klapheke, Primo N Lara, et al.
BJU International|June 15, 2025
A decade review of mental health monitoring in clinical trials for United States Food and Drug Administration-approved genitourinary cancer treatmentsFarzad Teymouri, Parnian Jabbari, Omid Yazdanpanah, et al.
Reproductive Biology and Endocrinology : RB&E|March 24, 2011
Proteomics: a subcellular look at spermatozoaStefan S du Plessis, Anthony H Kashou, David J Benjamin, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2023
Correction: Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registryDavid J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.
Prostate Cancer and Prostatic Diseases|October 5, 2023
Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registryDavid J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.
BJU International|March 28, 2025
Monitoring and reporting sexual health adverse events for genitourinary cancer therapiesDavid J Benjamin, Charles A Loeb, Robert R Torrey, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Frontiers in Urology|August 8, 2025
Editorial: An outlook on urobiome: advances in understanding the role of urobiome in urological health and disease and its potential in biotherapeuticsHarris Onywera, Ramadhani Chambuso, David J Benjamin, et al.
JAMA Oncology|September 12, 2022
Association of Sociodemographic Characteristics With Survival Among Patients With Urachal Cancer in California From 1988 to 2019David J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
The Journal of Urology|November 24, 2012
Reproductive potential of men with obstructive azoospermia undergoing percutaneous sperm retrieval and intracytoplasmic sperm injection according to the cause of obstructionSandro C Esteves, Walter Lee, David J Benjamin, et al.
Clinical Lung Cancer|August 4, 2019
A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer RegistryDavid J Benjamin, Amy Klapheke, Primo N Lara, et al.
BJU International|June 15, 2025
A decade review of mental health monitoring in clinical trials for United States Food and Drug Administration-approved genitourinary cancer treatmentsFarzad Teymouri, Parnian Jabbari, Omid Yazdanpanah, et al.
Reproductive Biology and Endocrinology : RB&E|March 24, 2011
Proteomics: a subcellular look at spermatozoaStefan S du Plessis, Anthony H Kashou, David J Benjamin, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2023
Correction: Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registryDavid J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.
Prostate Cancer and Prostatic Diseases|October 5, 2023
Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registryDavid J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.
BJU International|March 28, 2025
Monitoring and reporting sexual health adverse events for genitourinary cancer therapiesDavid J Benjamin, Charles A Loeb, Robert R Torrey, et al.
Pageof 9